by SBG San Antonio Staff Reports Texas Biomed has broadened the scope of its vaccine research to include Avian Influenza amid recent concerns.
These will be intended to combat strains that mirror those found in cows and chickens, and now one person in Texas. “Thankfully, the risk of the current H5N1 case becoming widespread among people remains low,” says Larry Schlesinger, M.D., Texas Biomed President and CEO. “But viruses adapt and evolve – especially influenza viruses – which is why it is so critical to be studying them and developing vaccines and treatments well before they are needed.”
The new initiative, hosted by Professor Luis Martinez-Sobrido, Ph.D.’s laboratory, will see the scope of research increased to include Avian Influenza, testing if current vaccines and antivirals would have any effect on stopping the spread or mitigating the virus’ impact.
SAN ANTONIO United States Texas Biomed Texas United States Luis Martinez-Sobrido Larry Schlesinger Martinez- Influenza A Virus Influenza Avian Influenza Influenza Pandemic Orthomyxoviridae Antiviral Drug Transmission And Infection Of H5N1 Influenza A Virus Subtype H5N1
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: TODAYshow - 🏆 389. / 55 Read more »
Source: Gizmodo - 🏆 556. / 51 Read more »
Source: washingtonpost - 🏆 95. / 72 Read more »
Source: NBCNewYork - 🏆 270. / 63 Read more »
Source: FOX4 - 🏆 289. / 63 Read more »
Source: NBCDFW - 🏆 288. / 63 Read more »